½üÈÕ£¬Ð±¦GGÐÔÃü¿ÆÑ§Ñ§Ôº·Ç±àÂëRNAÓë°©Ö¢³¢ÊÔÊÒ¸±½ÌÊÚÀîÑÞÀû½áºÏ¸´µ©´óѧ´ÓÊôÖ×ÁöÒ½ÔºÉÛÑîºÍÀ¥Ã÷Ò½¿Æ´óѧµÚÈý´ÓÊôÒ½ÔºÍõÉܼѿÎÌâ×é·¢ÏÖÁËÔÚÂѳ²°©Öеͱí°×µÄhsa_circ_0001546ͨ¹ý½áºÏ14-3-3µ°°×ÍÆ½øTauµ°°×Á×Ëữ²¢ÓÕµ¼Tauµ°°×ÜöÝÍ£¬½ø¶øÍƽøÖ¬ÖʹýÑõ»¯ÎïµÄ²úÉú£¬ÓÕµ¼ÌúéæÃü£¬×îÖÕÔÚÌå±íºÍÌåÄÚÒÖÔìÂѳ²°©×ªÒƵÄлúÔ죬¸Ã¹¤×÷ÒÔTau Aggregation-Dependent Lipid Peroxide AccumulationDriven by the hsa_circ_0001546/14-3-3/CAMK2D/TauComplex Inhibits Epithelial Ovarian Cancer PeritonealMetastasisΪÌâ°ä·¢ÓÚ³ÛÃûÆÚ¿¯Advanced ScienceÔÓÖ¾£¨¿ÆÑ§Ôº·ÖÇøÒ»Çø£¬Ó°ÏìÒò×Ó15.1£©¡£
ÌúéæÃüÊÇÒ»ÖÖÓÉÌúÒÀÀµµÄÁ×Ö¬¹ýÑõ»¯ÒýÆðµÄÐÂÐÍ·¨Ê½ÐÔϸ°ûéæÃü£¬ÔÚ°©Ö¢×êÑеÄÔçÆÚ½×¶Î¾Í±»·¢ÏÖÓë°©Ö¢Ç×êÇÓйء£ÌúéæÃüµÄÁ½¸öÖØÒª·Ö×Ó»úÔìÔ̺¬Ö¬ÖʹýÑõ»¯ºÍµäÐ͵ÄGPX4µ÷½ÚµÄÌúéæÃüõè¾¶£¬¶øÖ¬ÖʹýÑõ»¯ÎLPOs£©µÄ¶Ñ¼¯ÊÇÌúéæÃüµÄ±êÖ¾¡£Ä¿Ç°Tauµ°°×ÓëÌúéæÃüµÄ¹ØÏµ³ÉΪÁË×êÑÐÈȵ㣬ֻ¹ÜÔÚÉñ¾ÍËÐÐÐÔ¼²²¡ÖÐÒѾ²ûÁËÈ»TauºÍÌúéæÃüµÄ¹ØÏµ£¬µ«ÔÚ°©Ö¢ÖÐÒÀÈ»²»×ãÓйصÄ×êÑС£
¸¹Ç»ÄÚÀ©É¢ÊÇÉÏÆ¤ÐÔÂѳ²°©£¨EOC£©×ªÒƵÄÖØÒª·½Ê½£¬ÆäÔ¤ºó²î¡¢¸´·¢Âʸߡ£»·×´RNA£¨circRNA£©ÊÇÆðÔ´ÓÚǰÌåmRNA£¨pre-mRNA£©µÄ¹²¼Û¹ØºÏµÄµ¥Á´×ªÂ¼±¾£¬²Î¼Óµ÷¿Ø¶àÖÖ°©Ö¢µÄ·¢Õ¹¡£±¾×êÑÐͨ¹ý¶ÔÕý³£Âѳ²×éÖ¯ºÍÂѳ²°©×éÖ¯½øÐÐRNA-seq¶þ´ú²âÐòɸѡµÃµ½²î¾àÐԵͱí°×µÄhsa_circ_0001546£¬²¢ÇÒÓëÕý³£Âѳ²×éÖ¯Ïà±È£¬hsa_circ_0001546ÔÚEOCÔλÔîºÍ×ªÒÆÔîÖеͱí°×£¬×¢Ã÷Æä¶ÔEOC×ÜÉú¼ÆÆÚ£¨OS£©ºÍÎÞ²¡Éú¼ÆÆÚ£¨DFS£©ÓµÓÐÓÅÁ¼µÄÓ°Ïì¡£±¾×êÑÐͨ¹ýRNA pull-down¡¢ÖÊÆ×¼ì²âºÍRNA½áºÏµ°°×ÃâÒß³Áµí£¨RIP£©³¢ÊÔ·¢ÏÔìä¿ÉÄÜÓë14-3-3µ°°×¼Ò×åµÄ¶à¸ö³ÉÔ±½áºÏ¡£¼øÓÚ14-3-3µ°°×¼Ò×å³ÉÔ±ÓµÓи߶ÈͬԴÐÔ£¬×÷Õß½øÒ»²½×êÑÐÁËhsa_circ_0001546Óë¸Ãµ°°×½áºÏµÄ¾ßÌåλµã¡£°ÎÈ¡½áºÏ·á¶È×î¸ßµÄµ°°×³ÉÔ±YWHAHµ°°××÷Ϊģ°å£¬Á˾ÖÖ¤Ã÷hsa_circ_0001546ÓëYWHAHµ°°×µÄµÚ165-186aaÇøÓò½áºÏ¡£½øÒ»²½£¬ÀûÓÃÃâÒß¹²³Áµí£¨Co-IP£©ºÍÔλÁÚ½üÏνӣ¨PLA£©µÈ³¢ÊÔ·¢ÏÖhsa_circ_0001546ͨ¹ýÍÆ½ø14-3-3½éµ¼µÄCAMK2DµÄÕÐļ¶øÍƽøTauµ°°×Á×Ëữ£¬´Ó¶øÊ¹14-3-3½áºÏµÄTauµ°°×´Ó·ÇÁ×Ëữת±äΪÁ×Ëữ£¨Ser324£©£¬µ¼ÖÂTauµ°°×ÜöÝÍÔö³¤£¬´Ó¶øÓÕµ¼LPOsµÄ¶Ñ¼¯²¢µ¼ÖÂLPOÒÀÀµÐÔÌúéæÃü¡£ÔÚÌåÄÚ£¬ÓÃÌúéæÃüÒÖÔì¼Áferrostatin-1ºÍTauµ°°×ÒÖÔì¼ÁTRx0237Ò½ÖÎÄܹ»×è¶Ïhsa_circ_0001546¶ÔEOCϸ°ûÀ©É¢µÄÒÖÔì×÷Óã¬ÒýÆð¸üÏÔÖøµÄ¸¹Ä¤ÖÖÖ²×ªÒÆ¡£

ÌåÄÚ³¢ÊÔÅú×¢hsa_circ_0001546/14-3-3/CAMK2D/p-Tau¸´ºÏÌåͨ¹ýÓÕµ¼TauÓйصÄÌúéæÃüÒÖÔìEOCÖ×Áö×ªÒÆ
×ÛÉÏËùÊö£¬¸Ã×êÑÐÁ˾ÖΪhsa_circ_0001546/14-3-3/CAMK2D/Tau¸´ºÏÎïµÄ´æÔÚÌṩÁËеÄÖ¤¾Ý£¬Tauµ°°×ÜöÝ͵¼ÖµÄÌúéæÃü²»½ö´æÔÚÓÚ°¢¶û´Äº£Ä¬²¡»òÅÁ½ðɲ¡µÈÉñ¾ÍËÐÐÐÔ¼²²¡ÓйØÏ¸°ûÖУ¬»¹²úÉúÔÚEOCϸ°ûÖУ¬²¢ÇÒÕâÖÖÓÉhsa_circ_0001546/14-3-3/CAMK2D/Tau¸´ºÏÎïÇý¶¯µÄÌúéæÃüÊÇLPOÒÀÀµÐԵ쬶ø²»ÊÇGPX4ÒÀÀµÐԵġ£±¾×êÑÐͨ¹ýһϵÁÐË÷Çó´ÓÌúéæÃü½Ç¶È̽Ë÷ÁËhsa_circ_0001546µÄÖ°ÄÜ£¬ÎªÂѳ²°©µÄÁÙ´²Õï¶ÏºÍ°ÐÏòÒ½ÖÎÌṩеİбꡣ

»·×´RNAhsa_circ_0001546ÒÖÔìEOC×ªÒÆµÄ»úÀíͼ
б¦GG˶ʿ×êÑÐÉú²ñ±òÊ磬¸´µ©´óѧ´ÓÊôÖ×ÁöÒ½ÔºÖ÷ÖÎҽʦÎâÓºÍÀ¥Ã÷Ò½¿Æ´óѧµÚÈý´ÓÊôҽԺ˶ʿ×êÑÐÉúÑîºã»ÛΪ¹²Í¬µÚÒ»×÷Õß¡£Ð±¦GGÀîÑÞÀû¸±½ÌÊÚ¡¢¸´µ©´óѧ´ÓÊôÖ×ÁöÒ½ÔºÉÛÑîÖúÀí×êÑÐÔ±¼°À¥Ã÷Ò½¿Æ´óѧµÚÈý´ÓÊôÒ½ÔºÍõÉܼѸ±Ö÷ÈÎҽʦΪ¹²Í¬Í¨Ñ¶×÷Õß¡£
ÎÄÕÂÁ´½Ó£ºhttps://doi.org/10.1002/advs.202310134